Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: Analysis of the UNOS data

Transplantation

Volumn 92, Issue 7, 2011, Pages 809-814

  Waki, Kayo ^a,b   Sugawara, Yasuhiko ^b   Tamura, Sumihito ^b   Mieno, Makiko Naka ^c   Yamashiki, Noriyo ^b   Kadowaki, Takashi ^b   Kokudo, Norihiro ^b  

^a TERASAKI FOUNDATION LABORATORY   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Deceased donor; Hepatitis infection; Long term; Survival; Transplant

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; ORGAN DONOR; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; COHORT STUDIES; COMORBIDITY; FEMALE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 81155160167     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31822d4dc3     Document Type: Article

References (41)

1. Crockett SD, Keeffe EB. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 2005; 4: 13.
2. Bellecave P, Gouttenoire J, Gajer M, et al. Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference. Hepatology 2009; 50: 46.
3. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitisCinfection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
4. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32: 673.
5. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002; 36: 202.
6. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999; 117: 619.
7. Neumann UP, Berg T, Bahra M, et al. Long-term outcome of liver transplants for chronic hepatitis C: A 10-year follow-up. Transplantation 2004; 77: 226.
8. Lake RJ, Shorr SJ, Bettina JS, et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549.
9. Limquiaco JL, Wong J, Wong VW, et al. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: A seven-year follow-up study. J Med Virol 2009; 81: 224.
10. Futagawa Y, Terasaki PI, Waki K, et al. No improvement in long-term liver transplant graft survival in the last decade: An analysis of the UNOS data. Am J Transplant 2006; 6: 1398.
11. Kim WR, Poterucha JJ, Kremers WK, et al. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004; 10: 968.
12. Liu Z, Hou J. Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. Int J Med Sci 2006; 3: 57.
13. Chu CJ, Lee SD. Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 2008; 23: 512.
14. Mohamed Ael S, al Karawi MA, et al. Dual infection with hepatitis C and B viruses: Clinical and histological study in Saudi patients. Hepatogastroenterology 1997; 44: 1404.
15. Zarski JP, Bohn B, Bastie A, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28: 27.
16. Sagnelli E, Pasquale G, Coppola N, et al. Influence of chronic coinfection with hepatitis B and C virus on liver histology. Infection 2004; 32: 144.
17. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitisCviral genotypes. Hepatology 1994; 19: 1321.
18. Huang EJ, Wright TL, Lake JR, et al. Hepatitis B and C coinfections and persistent hepatitis B infections: Clinical outcome and liver pathology after transplantation. Hepatology 1996; 23: 396.
19. Rifai K, Wedemeyer H, Rosenau J, et al. Longer survival of liver transplant recipients with hepatitis virus coinfections. Clin Transplant 2007; 21: 258.
20. Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. Hepatology 1996; 24: 1327.
21. McGory RW, Ishitani MB, Oliveira WM, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996; 61: 1358.
22. Sawyer RG, McGory RW, Gaffey MJ, et al. Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg 1998; 227: 841.
23. Dienstag JL, Perrillo RP, Schiff ER, et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657.
24. Han SH, Ofman J, Holt C, et al. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy. Liver Transpl 2000; 6: 741.
25. Marzano A, Salizzoni M, Debernardi-Venon W, et al. Prevention of hepatitis B virus recurrence after liver transplantation in cirrhotic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol 2001; 34: 903.
26. Mutimer D, Feraz-Neto BH, Harrison R, et al. Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: Rapid resolution during treatment with adefovir. Gut 2001; 49: 860.
27. Roberts MS, Angus DC, Bryce CL, et al. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886.
28. Waki K, Tamura S, Sugawara Y, et al. An analysis of the OPTN/UNOS liver transplant registry. In: Cecka JM, Terasaki PI, eds. Clinical transplantation, vol. 1 [ed. 25]. Los Angeles, CA: Terasaki Foundation Laboratory 2010, p 13.
29. Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007; 13: 1236.
30. Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002; 360: 1943.
31. Alabraba E, Nightingale P, Gunson B, et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver Transpl 2009; 15: 330.
32. Kemmer NM, Neff GW. Liver transplantation trends and survival in the Asian population. Transplantation 2009; 88: 392.
33. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California. Hepatology 2007; 46: 1034.
34. Transplants in the U.S. by Recipient Ethnicity. Available at: http://optn. transplant.hrsa.gov/latestData/rptData.asp. Accessed 12 January, 2010.
35. Dickinson DM, Bryant PC, Williams MC, et al. Transplant data: Sources, collection, and caveats. Am J Transplant 2004; 4 (suppl 9): 13.
36. El-Serag HB, Lau M, Eschbach K, et al. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med 2007; 167: 1983.
37. Wong R, Corley DA. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med 2008; 121: 525.
38. Brady CW, Smith AD, Stechuchak KM, et al. Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era. Liver Transpl 2008; 14: 228.
39. Nair S, Thuluvath PJ. Does race-matched liver transplantation offer any graft survival benefit? Transplant Proc 2001; 33: 1523.
40. Nair S, Eustace J, Thuluvath PJ. Effect of race on outcome of orthotopic liver transplantation: A cohort study. Lancet 2002; 359: 287.
41. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783.